Arabesque Asset Management LTD Vertex Pharmaceuticals Inc Transaction History

Arabesque Asset Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $2.41 Million - $2.71 Million	8,421 New	8,421 $2.43 Million
Q1 2021 May 17, 2021	SELL	$207.02 - $241.31 $740,303 - $862,924	-3,576 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $1.25 Million - $1.67 Million	-6,039 Reduced 62.81%	3,576 $845,000
Q3 2020 Nov 16, 2020	SELL	$255.65 - $303.1 $563,963 - $668,638	-2,206 Reduced 18.66%	9,615 $2.62 Million
Q2 2020 Oct 22, 2020	SELL	$225.48 - $295.8 $431,343 - $565,865	-1,913 Reduced 13.93%	11,821 $3.43 Million
Q1 2020 Apr 17, 2020	BUY	$199.77 - $247.81 $2.74 Million - $3.4 Million	13,734 New	13,734 $3.27 Million

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Arabesque Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Arabesque Asset Management LTD with notifications on news.